APA

Schackert C., Korting H. C. & Schäfer-Korting M. (20100520). Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Chicago

Schackert C, Korting H C and Schäfer-Korting M. 20100520. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Harvard

Schackert C., Korting H. C. and Schäfer-Korting M. (20100520). Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

MLA

Schackert C, Korting H C and Schäfer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. : BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 20100520.